Navigation Links
22 of America's Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences

PHILADELPHIA, June 14, 2011 /PRNewswire-USNewswire/ -- Twenty-two of America's most promising scientists have been named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts.  The 2011 Pew Scholars will join a select community that includes MacArthur Fellows, recipients of the Albert Lasker Medical Research Award and three Nobel Prize winners.  Research by the new class of Scholars is related to many human diseases ranging from Alzheimer's to diabetes to ocular degeneration. The program encourages early-career scientists to advance research that leads to important medical breakthroughs and treatments.

"Pew is pleased to provide this country's most ambitious and dedicated scientists with timely funding that enables them to explore novel areas of investigation early in their careers, at what may be the most inventive and creative period in their research," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts.


To date, the program has invested more than $125 million to fund over 500 scholars. It is a rigorously competitive program where recipients receive $240,000 over four years to pursue their research without restriction. Applicants who work in all areas of physical and life sciences related to biomedical study must be nominated by an invited institution and demonstrate both excellence and innovation in their research. This year, 175 institutions were requested to nominate a candidate and 136 eligible nominations were received.

"Early recognition of young scientists with ideas that challenge their fields is essential for the vitality of the biomedical sciences," said Craig C. Mello, Ph.D., a 1995 Pew Scholar, a 2006 Nobel Laureate in Physiology or Medicine and the chair of the national advisory committee for the program. "From my own experience as a Pew Scholar and member of the advisory board, this program gives young scientists the confidence to pursue risky projects, and to push the boundaries of their fields, planting the seeds for major scientific advancements.  I welcome these promising scientists into the Pew Biomedical Scholars family and look forward to watching as their research unfolds in the years ahead."

The new 2011 Pew Scholars are:

  • Christine M. Dunham, Ph.D.

  • Emory University School of Medicine Structural Biology and Pathogenesis

  • Thomas G. Fazzio, Ph.D.

  • University of Massachusetts Medical SchoolStem Cell Biology

  • Max L. Fletcher, Ph.D.

  • University of Tennessee Health Science CenterNeuroscience

  • Hunter B. Fraser, Ph.D.

  • Stanford UniversityGene Regulation

  • Melissa K. Gardner, Ph.D.

  • University of MinnesotaCell Biology and Biophysics

  • Mary Gehring, Ph.D.

  • Whitehead Institute for Biomedical ResearchGene Regulation and Epigenetics

  • Jeff Gore, Ph.D.

  • Massachusetts Institute of TechnologyBiophysics and Systems Biology

  • Takaki Komiyama, Ph.D.

  • University of California, San DiegoNeuroscience

  • Mei Kong, Ph.D.

  • Beckman Institute, City of Hope Cancer Cell Biology

  • Michael S. Kuhns, Ph.D.

  • University of ArizonaImmunology

  • Erica Larschan, Ph.D.

  • Brown UniversityEpigenetics

  • Eros Lazzerini Denchi, Ph.D.

  • Scripps Research InstituteAging and Stem Cell Biology

  • Ann C. Morris, Ph.D.

  • University of KentuckyDevelopmental Neurobiology and Genetics

  • James B. Moseley, Ph.D.

  • Dartmouth Medical SchoolCell Biology

  • Suzanne M. Nobel, M.D., Ph.D.

  • University of California, San FranciscoFungal Pathogenesis

  • Brad J. Nolen, Ph.D.

  • University of OregonStructural Biology

  • Chad G. Pearson, Ph.D.

  • University of Colorado, DenverCell Biology

  • Sharad Ramanathan, Ph.D.

  • Harvard University Neuroscience and Systems Biology

  • Anthony R. Richardson, Ph.D.

  • University of North Carolina at Chapel HillMicrobiology and Immunology

  • Niels Ringstad, Ph.D.

  • New York University School of MedicineNeuroscience

  • Georgios Skiniotis, Ph.D.

  • University of MichiganStructural Biology and Membrane Biology

  • Liang Zhou, M.D., Ph.D.

  • Northwestern UniversityImmunology and Gene RegulationFor full biographies and information regarding the scholars' research, please visit

    The Pew Charitable Trusts ( is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. We partner with a diverse range of donors, public and private organizations and concerned citizens who share our commitment to fact-based solutions and goal-driven investments to improve society.

    SOURCE The Pew Charitable Trusts
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
    2. iLife Americas, LLC Enters U.S. Wellness and Therapeutic Markets
    3. Americas on the Waterway Supports US Oncology Foundation
    4. Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education
    5. Abbott to Present at UBS Best of Americas Investment Conference
    6. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
    7. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
    8. Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients
    9. Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
    10. New findings promising for transformation optics, cloaking
    11. New hydrolysis model promising tool in cellulosic biofuel studies
    Post Your Comments:
    (Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
    (Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
    (Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
    (Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
    Breaking Biology Technology:
    (Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
    (Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
    (Date:10/29/2015)... 29, 2015   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that it ... (MHTA) as one of only three finalists for a ... Small and Growing" category. The Tekne Awards honor ... superior technology innovation and leadership. iMedNet™ ...
    Breaking Biology News(10 mins):